Exigyn Information

Exigyn is an AI-enabled biotech and life sciences advisory firm built for a new era of drug development — where scientific velocity is accelerating, capital is constrained, and decisions need to be both faster and more defensible. We partner with early- and mid-stage biotech companies, as well as select commercial-stage organizations, to translate complex science into clear strategy, credible financial plans, and compelling investor narratives. Our team consists of former biotech operators — executives who have built, financed, and scaled companies firsthand. We don’t operate as external advisors; we embed alongside leadership teams to drive decisions that are practical, rigorous, and executable in real-world conditions. What differentiates Exigyn is our tech-enabled model. Alongside high-touch advisory, we deploy proprietary platforms and AI-powered tools to deliver dynamic planning, real-time scenario modeling, and decision support. Our clients move beyond static decks and spreadsheets to living systems that evolve with their business. We focus on the decisions that matter most: Strategic FP&A, budgeting, and long-range planning Product and scientific positioning Pipeline and commercial valuation Fundraising strategy and investor messaging Embedded, operator-style finance and strategy support Our engagements are flexible — from targeted projects to ongoing partnerships — meeting companies from formation through clinical development and commercialization. At Exigyn, we help biotech teams turn insight into action — and strategy into momentum.